StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Merck (MRK) PT Raised to $67 at Cowen
April 20, 2018 6:21 AM
(Updated - April 20, 2018 8:07 AM EDT)
Cowen raised its price target on Merck (NYSE: MRK) to $67.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
Merck (MRK) Reports EMA Validation of Type II Variation for KEYTRUDA (pembrolizumab) in Combination with Pemetrexed (ALIMTA) and Platinum Chemotherapy
April 23, 2018 4:35 PM
Goldman Sachs Double Upgrades Merck (MRK) to Conviction Buy
April 23, 2018 5:22 AM
Merck (MRK) PT Raised to $74 at JPMorgan
April 20, 2018 4:42 AM
Merck (MRK) PT Lowered to $67 at Bernstein
April 18, 2018 9:26 AM
Merck (MRK) PT Raised to $70 at BofA/Merrill Lynch, 'Merck emerging as clear IO winner in lung'
April 18, 2018 8:25 AM
